Axillary node metastases in relation to size and location of breast cancers: Analysis of 147 patients

American Surgeon

Volumn 62, Issue 7, 1996, Pages 519-524

  Kambouris, Angelos A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER LOCALIZATION; CANCER SIZE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0029936094     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Danforth MS Jr. The role of axillary lymph node dissection in management of breast cancer. Princ Pract Oncol 1992;6:1-16.
2. Ruffin WK, Stacey-Clear A, Younger J, Hoover HC, Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg 1995;180:245-51.
3. 1a breast carcinoma. Is it indicated? Cancer 1994;73:664-7.
4. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 1994;73:505-8.
5. Cady B, Stone, MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993;218:338-49.
6. Haffty BG, McKhann C, Beinfield M, et al. Breast conservation therapy without axillary dissection. A rational treatment strategy in selected patients. AMA Arch Surg 1993;128:1315-9.
7. Wazer DE, Erban JK, Robert NJ, et al. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 1994;74:878-83.
8. Hermann RE, Esselstyn CB, Grundfest-Boniatowski S, et al. Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breast. Surg Gynecol Obstet 1993;177:247-53.
9. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9:988-96.
10. Sunderland MC, McGuire WL. Prognostic indicators in invasive breast cancer. Surg Clin N Am 1990;70:989-1004.
11. Stierer M, Rosen HR, Weber R, et al. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynecol Obstet 1992;175:151-60.
12. O'Reilly SM, Camplejohn RS, Barnes DM, et al. Node negative breast cancer: Prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol 1990;8:2040-6.
13. Yamashita J, Ogawa M, Sakai K. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer. Surgery 1995;117:601-8.
14. Menard S, Bufalino R, Rieke F, et al. Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer 1994;70:709-12.
15. Silverstein MJ, Gierson ED, Waisman JR, et al. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 1995;180:700-4.
16. Reger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 1989;157:501-2.
17. 1 breast cancer. A multivariate analysis. Cancer 1994;73:350-3.
18. Seidman JD, Schnapper LA, Aisner S. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer 1995;75:65-71.
19. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
20. 0) breast carcinoma. J Clin Oncol 1989;7:355-66.
21. Caceres E. An evaluation of extended radical mastectomy in the treatment of breast cancer. In: Breast Cancer: Early and Late, Chicago: Yearbook Medical Publishers Inc., 1970; pp 125-34.
22. Carbone P. Breast cancer adjuvant therapy. Cancer 1990; 66:1378-86.
23. Hortobagyi GN, Buzdar AV. Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy. CA Cancer J Clin 1995;45:199-226.
24. Fisher B. The revolution in breast cancer surgery: Science or anecdotalism? World J Surg 1985;9:655-66.
25. Morton DL, Wen D-R, Cochran AJ. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. Surg Oncol Clin N.A. 1992;1:247-59.